Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Inhibitors >  Omadacycline

Omadacycline

Basic information Safety Supplier Related

Omadacycline Basic information

Product Name:
Omadacycline
Synonyms:
  • AMadacycline
  • OMadacycline
  • PTK 0796
  • PTK-796
  • OMADACYCLINE; PTK 0796; PTK-0796; PTK0796; AMADACYCLINE
  • 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-[[(2,2-dimethylpropyl)amino]methyl]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-
  • Omadacycline-D9
  • Amadacycline,Omadacycline,PTK 0796
CAS:
389139-89-3
MF:
C29H40N4O7
MW:
556.65
Mol File:
389139-89-3.mol
More
Less

Omadacycline Chemical Properties

Boiling point:
837.6±65.0 °C(Predicted)
Density 
1.39±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMSO:1.0(Max Conc. mg/mL);1.8(Max Conc. mM)
form 
A crystalline solid
pka
4.50±1.00(Predicted)
color 
Yellow to orange
Stability:
Hygroscopic
InChIKey
JEECQCWWSTZDCK-IQZGDKDPSA-N
SMILES
C1(=O)[C@]2(O)[C@@]([H])(C[C@@]3([H])C(=C2O)C(=O)C2=C(C(N(C)C)=CC(CNCC(C)(C)C)=C2O)C3)[C@H](N(C)C)C(O)=C1C(N)=O
More
Less

Omadacycline Usage And Synthesis

Description

Omadacycline, the drug that US FDA approved for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections. It is not susceptible to common tetracycline-resistancemechanisms, and has demonstrated efficacy against a broad spectrum of pathogens including resistant isolates, which are increasing in prevalence and complexity.

Uses

Omadacycline is a potent an demonstrates efficacy against both Bacillus anthracis and Yersinia pestis; Also, it is a novel aminomethylcycline antibiotic in clinical development for community-acquired bacterial pneumonia (CABP).

Definition

ChEBI: Omadacycline is a member of tetracyclines.

Pharmacology

Omadacycline has shown clinical efficacy in anaerobic acute bacterial skin and skin structure infections (ABSSSI) and in animal models of intra-abdominal anaerobic infections.The in vitro activity of Omadacycline against clinically relevant anaerobes was similar to that of tigecycline, with MIC90 values of 1 to 8 g/ml against Bacteroides spp, 0.5 g/ml against Clostridium difficile, Prevotella spp., and Porphyromonas asaccharolytica,1 g/ml against Peptostreptococcus spp, and 16 g/ml against Clostridium perfringens.

Side effects

OMadacycline may cause serious adverse reactions including hypersensitivity reactions, tooth discoloration,Clostridioides difficile-associated diarrhea, and reversible inhibition of bone growth when administered during the second and third trimesters of pregnancy.Common adverse reactions include nausea, vomiting, infusion site reactions, alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyl transferase increased, hypertension, headache, diarrhea, insomnia, and constipation.Mild to moderate nausea and vomiting were the most frequent treatment-emergent adverse events in omadacycline (111 [30%] of 368 and 62 [17%] of 368, respectively) groups.

OmadacyclineSupplier

Hubei Moco Chemical Co., Ltd. Gold
Tel
18627753421 18627756402
Email
3001009495@qq.com
Chembest Research Laboratories Limited
Tel
+86-21-20908456
Email
sales@BioChemBest.com
Shanghai Aladdin Bio-Chem Technology Co.,LTD
Tel
400-400-6206333 18521732826
Email
market@aladdin-e.com
AdooQ BioScience, LLC
Tel
+1 (866) 930-6790
Email
info@adooq.com
ShangHai Caerulum Pharma Discovery Co., Ltd.
Tel
18149758185 18149758185
Email
sales-cpd@caerulumpharma.com
More
Less

Omadacycline(389139-89-3)Related Product Information